Selected article for: "age specific biological susceptibility profile and biological susceptibility"

Author: Houssein H. Ayoub; Hiam Chemaitelly; Shaheen Seedat; Ghina R. Mumtaz; Monia Makhoul; Laith J Abu-Raddad
Title: Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide
  • Document date: 2020_4_17
  • ID: 9huyb4cs_25
    Snippet: This study has limitations. Model estimations are contingent on the validity and generalizability of input data. Our estimates were based on SARS-CoV-2 natural history and disease progression data from China, but these may not be applicable to other countries. The key factor driving the heterogeneity in transmission dynamics is the age-specific biological susceptibility profile. We All rights reserved. No reuse allowed without permission......
    Document: This study has limitations. Model estimations are contingent on the validity and generalizability of input data. Our estimates were based on SARS-CoV-2 natural history and disease progression data from China, but these may not be applicable to other countries. The key factor driving the heterogeneity in transmission dynamics is the age-specific biological susceptibility profile. We All rights reserved. No reuse allowed without permission.

    Search related documents:
    Co phrase search for related documents
    • age specific biological susceptibility profile and biological susceptibility profile: 1
    • age specific biological susceptibility profile and natural history: 1
    • age specific biological susceptibility profile and SARS natural history: 1
    • biological susceptibility and disease progression: 1
    • biological susceptibility and natural history: 1
    • biological susceptibility and SARS natural history: 1
    • biological susceptibility profile and natural history: 1
    • biological susceptibility profile and SARS natural history: 1
    • disease progression and key factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • disease progression and model estimation: 1, 2
    • disease progression and natural history: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease progression and SARS natural history: 1, 2, 3
    • disease progression and transmission dynamic: 1, 2, 3
    • key factor and natural history: 1
    • key factor and transmission dynamic: 1, 2
    • model estimation and natural history: 1, 2, 3
    • model estimation and SARS natural history: 1
    • model estimation and transmission dynamic: 1, 2, 3, 4
    • natural history and SARS natural history: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25